Literature DB >> 10073262

Intestinal pseudo-obstruction.

B Coulie1, M Camilleri.   

Abstract

Pseudo-obstruction syndromes are increasingly recognized in clinical practice. They result from impairment of intrinsic neuromuscular or extrinsic control of gut motility. Typically, pseudo-obstruction syndromes result in features suggestive of mechanical obstruction and bowel dilatation in the absence of any demonstrable obstruction or mucosal disease. The syndrome may affect any region of the gut. Less severe variants without bowel dilatation are diagnosed by measurement of gastrointestinal transit and pressure profiles. The aims of treatment are restoration of nutrition and hydration, symptom relief, normalization of intestinal propulsion with prokinetics, and suppression of bacterial overgrowth. Surgery plays a limited role, adjunctive to medical treatment, facilitating enteral nutrition and decompression by means of jejunostomy. Infrequently, resection of localized disease or intestinal transplantation are indicated. The roles of intestinal pacemakers (interstitial cells of Cajal) and genetic mutations in the etiology of pseudo-obstruction, as well as the cost-benefit ratio of transplantation for pseudo-obstruction, will be clarified in the future.

Entities:  

Mesh:

Year:  1999        PMID: 10073262     DOI: 10.1146/annurev.med.50.1.37

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  15 in total

Review 1.  Treating irritable bowel syndrome: overview, perspective and future therapies.

Authors:  Michael Camilleri
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

Review 2.  Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction.

Authors:  R De Giorgio; G Sarnelli; R Corinaldesi; V Stanghellini
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

3.  Acute on chronic intestinal pseudo-obstruction as a cause of death in a previously healthy twenty-year-old male.

Authors:  Joshua T Evans; Mark H Delegge; Christopher Lawrence; David Lewin
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

Review 4.  Interstitial cells of Cajal in the gut--a gastroenterologist's point of view.

Authors:  Lucian M Negreanu; Philippe Assor; Bogdan Mateescu; Catalin Cirstoiu
Journal:  World J Gastroenterol       Date:  2008-11-07       Impact factor: 5.742

5.  Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders.

Authors:  Hirotada Akiho; Eikichi Ihara; Yasuaki Motomura; Kazuhiko Nakamura
Journal:  World J Gastrointest Pathophysiol       Date:  2011-10-15

6.  JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction.

Authors:  M Selgrad; R De Giorgio; L Fini; R F Cogliandro; S Williams; V Stanghellini; G Barbara; M Tonini; R Corinaldesi; R M Genta; R Domiati-Saad; R Meyer; A Goel; C R Boland; L Ricciardiello
Journal:  Gut       Date:  2008-07-01       Impact factor: 23.059

7.  Neural mechanisms underlying migrating motor complex formation in mouse isolated colon.

Authors:  S M Brierley; K Nichols; D J Grasby; S A Waterman
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

8.  Chronic Intestinal Pseudo-Obstruction.

Authors:  Kashyap V Panganamamula; Henry P Parkman
Journal:  Curr Treat Options Gastroenterol       Date:  2005-02

9.  Treatment of intestinal pseudo obstruction by segmental resection.

Authors:  A Nayci; D Avlan; A Polat; S Aksoyek
Journal:  Pediatr Surg Int       Date:  2002-12-13       Impact factor: 1.827

10.  Neurogenic chronic intestinal pseudo-obstruction: antineuronal antibody-mediated activation of autophagy via Fas.

Authors:  Roberto de Giorgio; Umberto Volta; Vincenzo Stanghellini; Rosanna F Cogliandro; Giovanni Barbara; Roberto Corinaldesi; Roberto Towns; Chunfang Guo; Shuangsong Hong; John W Wiley
Journal:  Gastroenterology       Date:  2008-05-15       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.